Global and China OTC Anti-Infective Products Market Insights, Forecast to 2027

Global and China OTC Anti-Infective Products Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 OTC Anti-Infective Products Product Introduction
1.2 Market by Type
1.2.1 Global OTC Anti-Infective Products Market Size Growth Rate by Type
1.2.2 Antifungals
1.2.3 Antiseptic
1.2.4 Antiparasitics
1.3 Market by Application
1.3.1 Global OTC Anti-Infective Products Market Size Growth Rate by Application
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Stores
1.3.5 E-Commerce
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global OTC Anti-Infective Products Market Size, Estimates and Forecasts
2.1.1 Global OTC Anti-Infective Products Revenue 2016-2027
2.1.2 Global OTC Anti-Infective Products Sales 2016-2027
2.2 Global OTC Anti-Infective Products, Market Size by Region: 2016 VS 2021 VS 2027
2.3 OTC Anti-Infective Products Historical Market Size by Region (2016-2021)
2.3.1 Global OTC Anti-Infective Products Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global OTC Anti-Infective Products Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 OTC Anti-Infective Products Market Estimates and Projections by Region (2022-2027)
2.4.1 Global OTC Anti-Infective Products Sales Forecast by Region (2022-2027)
2.4.2 Global OTC Anti-Infective Products Revenue Forecast by Region (2022-2027)
3 Global OTC Anti-Infective Products Competitor Landscape by Players
3.1 Global Top OTC Anti-Infective Products Manufacturers by Sales
3.1.1 Global OTC Anti-Infective Products Sales by Manufacturer (2016-2021)
3.1.2 Global OTC Anti-Infective Products Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top OTC Anti-Infective Products Manufacturers by Revenue
3.2.1 Key OTC Anti-Infective Products Manufacturers Covered: Ranking by Revenue
3.2.2 Global OTC Anti-Infective Products Revenue by Manufacturers (2016-2021)
3.2.3 Global OTC Anti-Infective Products Revenue Share by Manufacturers (2016-2021)
3.2.4 Global OTC Anti-Infective Products Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by OTC Anti-Infective Products Revenue in 2020
3.2.6 Global OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global OTC Anti-Infective Products Price by Manufacturers
3.4 Global OTC Anti-Infective Products Manufacturing Base Distribution, Product Types
3.4.1 OTC Anti-Infective Products Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers OTC Anti-Infective Products Product Type
3.4.3 Date of International Manufacturers Enter into OTC Anti-Infective Products Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global OTC Anti-Infective Products Market Size by Type (2016-2021)
4.1.1 Global OTC Anti-Infective Products Sales by Type (2016-2021)
4.1.2 Global OTC Anti-Infective Products Revenue by Type (2016-2021)
4.1.3 OTC Anti-Infective Products Average Selling Price (ASP) by Type (2016-2021)
4.2 Global OTC Anti-Infective Products Market Size Forecast by Type (2022-2027)
4.2.1 Global OTC Anti-Infective Products Sales Forecast by Type (2022-2027)
4.2.2 Global OTC Anti-Infective Products Revenue Forecast by Type (2022-2027)
4.2.3 OTC Anti-Infective Products Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global OTC Anti-Infective Products Market Size by Application (2016-2021)
5.1.1 Global OTC Anti-Infective Products Sales by Application (2016-2021)
5.1.2 Global OTC Anti-Infective Products Revenue by Application (2016-2021)
5.1.3 OTC Anti-Infective Products Price by Application (2016-2021)
5.2 OTC Anti-Infective Products Market Size Forecast by Application (2022-2027)
5.2.1 Global OTC Anti-Infective Products Sales Forecast by Application (2022-2027)
5.2.2 Global OTC Anti-Infective Products Revenue Forecast by Application (2022-2027)
5.2.3 Global OTC Anti-Infective Products Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China OTC Anti-Infective Products Market Size YoY Growth 2016-2027
6.1.1 China OTC Anti-Infective Products Sales YoY Growth 2016-2027
6.1.2 China OTC Anti-Infective Products Revenue YoY Growth 2016-2027
6.1.3 China OTC Anti-Infective Products Market Share in Global Market 2016-2027
6.2 China OTC Anti-Infective Products Market Size by Players (International and Local Players)
6.2.1 China Top OTC Anti-Infective Products Players by Sales (2016-2021)
6.2.2 China Top OTC Anti-Infective Products Players by Revenue (2016-2021)
6.3 China OTC Anti-Infective Products Historic Market Review by Type (2016-2021)
6.3.1 China OTC Anti-Infective Products Sales Market Share by Type (2016-2021)
6.3.2 China OTC Anti-Infective Products Revenue Market Share by Type (2016-2021)
6.3.3 China OTC Anti-Infective Products Price by Type (2016-2021)
6.4 China OTC Anti-Infective Products Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China OTC Anti-Infective Products Sales Forecast by Type (2022-2027)
6.4.2 China OTC Anti-Infective Products Revenue Forecast by Type (2022-2027)
6.4.3 China OTC Anti-Infective Products Price Forecast by Type (2022-2027)
6.5 China OTC Anti-Infective Products Historic Market Review by Application (2016-2021)
6.5.1 China OTC Anti-Infective Products Sales Market Share by Application (2016-2021)
6.5.2 China OTC Anti-Infective Products Revenue Market Share by Application (2016-2021)
6.5.3 China OTC Anti-Infective Products Price by Application (2016-2021)
6.6 China OTC Anti-Infective Products Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China OTC Anti-Infective Products Sales Forecast by Application (2022-2027)
6.6.2 China OTC Anti-Infective Products Revenue Forecast by Application (2022-2027)
6.6.3 China OTC Anti-Infective Products Price Forecast by Application (2022-2027)
7 North America
7.1 North America OTC Anti-Infective Products Market Size YoY Growth 2016-2027
7.2 North America OTC Anti-Infective Products Market Facts & Figures by Country
7.2.1 North America OTC Anti-Infective Products Sales by Country (2016-2021)
7.2.2 North America OTC Anti-Infective Products Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific OTC Anti-Infective Products Market Size YoY Growth 2016-2027
8.2 Asia Pacific OTC Anti-Infective Products Market Facts & Figures by Region
8.2.1 Asia Pacific OTC Anti-Infective Products Sales by Region (2016-2021)
8.2.2 Asia Pacific OTC Anti-Infective Products Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe OTC Anti-Infective Products Market Size YoY Growth 2016-2027
9.2 Europe OTC Anti-Infective Products Market Facts & Figures by Country
9.2.1 Europe OTC Anti-Infective Products Sales by Country (2016-2021)
9.2.2 Europe OTC Anti-Infective Products Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America OTC Anti-Infective Products Market Size YoY Growth 2016-2027
10.2 Latin America OTC Anti-Infective Products Market Facts & Figures by Country
10.2.1 Latin America OTC Anti-Infective Products Sales by Country (2016-2021)
10.2.2 Latin America OTC Anti-Infective Products Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa OTC Anti-Infective Products Market Size YoY Growth 2016-2027
11.2 Middle East and Africa OTC Anti-Infective Products Market Facts & Figures by Country
11.2.1 Middle East and Africa OTC Anti-Infective Products Sales by Country (2016-2021)
11.2.2 Middle East and Africa OTC Anti-Infective Products Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Corporation Information
12.1.2 GlaxoSmithKline Description and Business Overview
12.1.3 GlaxoSmithKline OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GlaxoSmithKline OTC Anti-Infective Products Products Offered
12.1.5 GlaxoSmithKline Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Description and Business Overview
12.2.3 Merck OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck OTC Anti-Infective Products Products Offered
12.2.5 Merck Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Description and Business Overview
12.3.3 Pfizer OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pfizer OTC Anti-Infective Products Products Offered
12.3.5 Pfizer Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Description and Business Overview
12.4.3 Novartis OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis OTC Anti-Infective Products Products Offered
12.4.5 Novartis Recent Development
12.5 Abbott
12.5.1 Abbott Corporation Information
12.5.2 Abbott Description and Business Overview
12.5.3 Abbott OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Abbott OTC Anti-Infective Products Products Offered
12.5.5 Abbott Recent Development
12.6 Sanofi
12.6.1 Sanofi Corporation Information
12.6.2 Sanofi Description and Business Overview
12.6.3 Sanofi OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sanofi OTC Anti-Infective Products Products Offered
12.6.5 Sanofi Recent Development
12.7 Bristol-Myers Squibb
12.7.1 Bristol-Myers Squibb Corporation Information
12.7.2 Bristol-Myers Squibb Description and Business Overview
12.7.3 Bristol-Myers Squibb OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Bristol-Myers Squibb OTC Anti-Infective Products Products Offered
12.7.5 Bristol-Myers Squibb Recent Development
12.8 Roche
12.8.1 Roche Corporation Information
12.8.2 Roche Description and Business Overview
12.8.3 Roche OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Roche OTC Anti-Infective Products Products Offered
12.8.5 Roche Recent Development
12.9 NanoViricides
12.9.1 NanoViricides Corporation Information
12.9.2 NanoViricides Description and Business Overview
12.9.3 NanoViricides OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
12.9.4 NanoViricides OTC Anti-Infective Products Products Offered
12.9.5 NanoViricides Recent Development
12.10 Novabay Pharmaceuticals
12.10.1 Novabay Pharmaceuticals Corporation Information
12.10.2 Novabay Pharmaceuticals Description and Business Overview
12.10.3 Novabay Pharmaceuticals OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Novabay Pharmaceuticals OTC Anti-Infective Products Products Offered
12.10.5 Novabay Pharmaceuticals Recent Development
12.11 GlaxoSmithKline
12.11.1 GlaxoSmithKline Corporation Information
12.11.2 GlaxoSmithKline Description and Business Overview
12.11.3 GlaxoSmithKline OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GlaxoSmithKline OTC Anti-Infective Products Products Offered
12.11.5 GlaxoSmithKline Recent Development
12.12 Basilea Pharmaceutica
12.12.1 Basilea Pharmaceutica Corporation Information
12.12.2 Basilea Pharmaceutica Description and Business Overview
12.12.3 Basilea Pharmaceutica OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Basilea Pharmaceutica Products Offered
12.12.5 Basilea Pharmaceutica Recent Development
12.13 MerLion Pharma
12.13.1 MerLion Pharma Corporation Information
12.13.2 MerLion Pharma Description and Business Overview
12.13.3 MerLion Pharma OTC Anti-Infective Products Sales, Revenue and Gross Margin (2016-2021)
12.13.4 MerLion Pharma Products Offered
12.13.5 MerLion Pharma Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 OTC Anti-Infective Products Industry Trends
13.2 OTC Anti-Infective Products Market Drivers
13.3 OTC Anti-Infective Products Market Challenges
13.4 OTC Anti-Infective Products Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 OTC Anti-Infective Products Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global OTC Anti-Infective Products Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Antifungals
Table 3. Major Manufacturers of Antiseptic
Table 4. Major Manufacturers of Antiparasitics
Table 5. Global OTC Anti-Infective Products Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 6. Global OTC Anti-Infective Products Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global OTC Anti-Infective Products Sales by Regions (2016-2021) & (K Units)
Table 8. Global OTC Anti-Infective Products Sales Market Share by Regions (2016-2021)
Table 9. Global OTC Anti-Infective Products Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global OTC Anti-Infective Products Sales Forecast by Region (2022-2027) & (K Units)
Table 11. Global OTC Anti-Infective Products Sales Market Share Forecast by Region (2022-2027)
Table 12. Global OTC Anti-Infective Products Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global OTC Anti-Infective Products Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global OTC Anti-Infective Products Sales by Manufacturers (2016-2021) (K Units)
Table 15. Global OTC Anti-Infective Products Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top OTC Anti-Infective Products Manufacturers by Revenue (US$ Million) in 2020
Table 17. OTC Anti-Infective Products Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. OTC Anti-Infective Products Revenue Share by Manufacturers (2016-2021)
Table 19. Global OTC Anti-Infective Products Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global OTC Anti-Infective Products by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OTC Anti-Infective Products as of 2020)
Table 21. Key Manufacturers OTC Anti-Infective Products Price (2016-2021) (USD/Unit)
Table 22. OTC Anti-Infective Products Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers OTC Anti-Infective Products Product Type
Table 24. Date of International Manufacturers Enter into OTC Anti-Infective Products Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global OTC Anti-Infective Products Sales by Type (2016-2021) (K Units)
Table 27. Global OTC Anti-Infective Products Sales Share by Type (2016-2021)
Table 28. Global OTC Anti-Infective Products Revenue by Type (2016-2021) (US$ Million)
Table 29. Global OTC Anti-Infective Products Revenue Share by Type (2016-2021)
Table 30. OTC Anti-Infective Products Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 31. Global OTC Anti-Infective Products Sales Forecast by Type (2022-2027) & (K Units)
Table 32. Global OTC Anti-Infective Products Sales Market Share Forecast by Type (2022-2027)
Table 33. Global OTC Anti-Infective Products Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global OTC Anti-Infective Products Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global OTC Anti-Infective Products Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 36. Global OTC Anti-Infective Products Sales by Application (2016-2021) (K Units)
Table 37. Global OTC Anti-Infective Products Sales Share by Application (2016-2021)
Table 38. Global OTC Anti-Infective Products Revenue by Application (2016-2021) (US$ Million)
Table 39. Global OTC Anti-Infective Products Revenue Share by Application (2016-2021)
Table 40. OTC Anti-Infective Products Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 41. Global OTC Anti-Infective Products Sales Forecast by Application (2022-2027) & (K Units)
Table 42. Global OTC Anti-Infective Products Sales Market Share Forecast by Application (2022-2027)
Table 43. Global OTC Anti-Infective Products Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global OTC Anti-Infective Products Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global OTC Anti-Infective Products Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 46. China OTC Anti-Infective Products Sales (K Units) of Key Companies (2016-2021)
Table 47. China OTC Anti-Infective Products Sales Share by Company (2016-2021)
Table 48. China OTC Anti-Infective Products Revenue (US$ Million) by Company (2016-2021)
Table 49. China OTC Anti-Infective Products Revenue Share by Company (2016-2021)
Table 50. China OTC Anti-Infective Products Sales (K Units) by Type (2016-2021)
Table 51. China OTC Anti-Infective Products Sales Share by Type (2016-2021)
Table 52. China OTC Anti-Infective Products Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China OTC Anti-Infective Products Price (USD/Unit) by Type (2016-2021)
Table 54. China OTC Anti-Infective Products Sales (K Units) by Type (2022-2027)
Table 55. China OTC Anti-Infective Products Sales Share by Type (2022-2027)
Table 56. China OTC Anti-Infective Products Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China OTC Anti-Infective Products Revenue Share by Type (2022-2027)
Table 58. China OTC Anti-Infective Products Price (USD/Unit) by Type (2022-2027)
Table 59. China OTC Anti-Infective Products Sales (K Units) by Application (2016-2021)
Table 60. China OTC Anti-Infective Products Sales Share by Application (2016-2021)
Table 61. China OTC Anti-Infective Products Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China OTC Anti-Infective Products Price (USD/Unit) by Application (2016-2021)
Table 63. China OTC Anti-Infective Products Sales (K Units) by Application (2022-2027)
Table 64. China OTC Anti-Infective Products Sales Share by Application (2022-2027)
Table 65. China OTC Anti-Infective Products Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China OTC Anti-Infective Products Revenue Share by Application (2022-2027)
Table 67. China OTC Anti-Infective Products Price (USD/Unit) by Application (2022-2027)
Table 68. North America OTC Anti-Infective Products Sales by Country (2016-2021) & (K Units)
Table 69. North America OTC Anti-Infective Products Sales Market Share by Country (2016-2021)
Table 70. North America OTC Anti-Infective Products Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America OTC Anti-Infective Products Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific OTC Anti-Infective Products Sales by Region (2016-2021) & (K Units)
Table 73. Asia Pacific OTC Anti-Infective Products Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific OTC Anti-Infective Products Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific OTC Anti-Infective Products Revenue Market Share by Region (2016-2021)
Table 76. Europe OTC Anti-Infective Products Sales by Country (2016-2021) & (K Units)
Table 77. Europe OTC Anti-Infective Products Sales Market Share by Country (2016-2021)
Table 78. Europe OTC Anti-Infective Products Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe OTC Anti-Infective Products Revenue Market Share by Country (2016-2021)
Table 80. Latin America OTC Anti-Infective Products Sales by Country (2016-2021) & (K Units)
Table 81. Latin America OTC Anti-Infective Products Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa OTC Anti-Infective Products Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America OTC Anti-Infective Products Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa OTC Anti-Infective Products Sales by Country (2016-2021) & (K Units)
Table 85. Middle East and Africa OTC Anti-Infective Products Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa OTC Anti-Infective Products Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa OTC Anti-Infective Products Revenue Market Share by Country (2016-2021)
Table 88. GlaxoSmithKline Corporation Information
Table 89. GlaxoSmithKline Description and Business Overview
Table 90. GlaxoSmithKline OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. GlaxoSmithKline OTC Anti-Infective Products Product
Table 92. GlaxoSmithKline Recent Development
Table 93. Merck Corporation Information
Table 94. Merck Description and Business Overview
Table 95. Merck OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Merck Product
Table 97. Merck Recent Development
Table 98. Pfizer Corporation Information
Table 99. Pfizer Description and Business Overview
Table 100. Pfizer OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Pfizer Product
Table 102. Pfizer Recent Development
Table 103. Novartis Corporation Information
Table 104. Novartis Description and Business Overview
Table 105. Novartis OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Novartis Product
Table 107. Novartis Recent Development
Table 108. Abbott Corporation Information
Table 109. Abbott Description and Business Overview
Table 110. Abbott OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Abbott Product
Table 112. Abbott Recent Development
Table 113. Sanofi Corporation Information
Table 114. Sanofi Description and Business Overview
Table 115. Sanofi OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Sanofi Product
Table 117. Sanofi Recent Development
Table 118. Bristol-Myers Squibb Corporation Information
Table 119. Bristol-Myers Squibb Description and Business Overview
Table 120. Bristol-Myers Squibb OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Bristol-Myers Squibb Product
Table 122. Bristol-Myers Squibb Recent Development
Table 123. Roche Corporation Information
Table 124. Roche Description and Business Overview
Table 125. Roche OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Roche Product
Table 127. Roche Recent Development
Table 128. NanoViricides Corporation Information
Table 129. NanoViricides Description and Business Overview
Table 130. NanoViricides OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. NanoViricides Product
Table 132. NanoViricides Recent Development
Table 133. Novabay Pharmaceuticals Corporation Information
Table 134. Novabay Pharmaceuticals Description and Business Overview
Table 135. Novabay Pharmaceuticals OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. Novabay Pharmaceuticals Product
Table 137. Novabay Pharmaceuticals Recent Development
Table 138. Optimer Pharmaceuticals Corporation Information
Table 139. Optimer Pharmaceuticals Description and Business Overview
Table 140. Optimer Pharmaceuticals OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. Optimer Pharmaceuticals Product
Table 142. Optimer Pharmaceuticals Recent Development
Table 143. Basilea Pharmaceutica Corporation Information
Table 144. Basilea Pharmaceutica Description and Business Overview
Table 145. Basilea Pharmaceutica OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 146. Basilea Pharmaceutica Product
Table 147. Basilea Pharmaceutica Recent Development
Table 148. MerLion Pharma Corporation Information
Table 149. MerLion Pharma Description and Business Overview
Table 150. MerLion Pharma OTC Anti-Infective Products Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 151. MerLion Pharma Product
Table 152. MerLion Pharma Recent Development
Table 153. OTC Anti-Infective Products Market Trends
Table 154. OTC Anti-Infective Products Market Drivers
Table 155. OTC Anti-Infective Products Market Challenges
Table 156. OTC Anti-Infective Products Market Restraints
Table 157. OTC Anti-Infective Products Customers List
Table 158. OTC Anti-Infective Products Distributors List
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. OTC Anti-Infective Products Product Picture
Figure 2. Global OTC Anti-Infective Products Sales Market Share by Type in 2020 & 2027
Figure 3. Antifungals Product Picture
Figure 4. Antiseptic Product Picture
Figure 5. Antiparasitics Product Picture
Figure 6. Global OTC Anti-Infective Products Sales Market Share by Application in 2020 & 2027
Figure 7. Hospital Pharmacies
Figure 8. Drug Stores
Figure 9. Retail Stores
Figure 10. E-Commerce
Figure 11. OTC Anti-Infective Products Report Years Considered
Figure 12. Global OTC Anti-Infective Products Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global OTC Anti-Infective Products Market Size 2016-2027 (US$ Million)
Figure 14. Global OTC Anti-Infective Products Sales 2016-2027 (K Units)
Figure 15. Global OTC Anti-Infective Products Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global OTC Anti-Infective Products Sales Market Share by Region (2016-2021)
Figure 17. Global OTC Anti-Infective Products Sales Market Share by Region in 2020
Figure 18. Global OTC Anti-Infective Products Revenue Market Share by Region (2016-2021)
Figure 19. Global OTC Anti-Infective Products Revenue Market Share by Region in 2020
Figure 20. Global OTC Anti-Infective Products Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by OTC Anti-Infective Products Revenue in 2020
Figure 22. OTC Anti-Infective Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global OTC Anti-Infective Products Sales Market Share by Type (2016-2021)
Figure 24. Global OTC Anti-Infective Products Sales Market Share by Type in 2020
Figure 25. Global OTC Anti-Infective Products Revenue Market Share by Type (2016-2021)
Figure 26. Global OTC Anti-Infective Products Revenue Market Share by Type in 2020
Figure 27. Global OTC Anti-Infective Products Sales Market Share by Application (2016-2021)
Figure 28. Global OTC Anti-Infective Products Sales Market Share by Application in 2020
Figure 29. Global OTC Anti-Infective Products Revenue Market Share by Application (2016-2021)
Figure 30. Global OTC Anti-Infective Products Revenue Market Share by Application in 2020
Figure 31. China OTC Anti-Infective Products Sales Growth Rate 2016-2027 (K Units)
Figure 32. China OTC Anti-Infective Products Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. China OTC Anti-Infective Products Market Share in Global Market 2016-2027
Figure 34. China 5 and 10 Largest OTC Anti-Infective Products Players Market Share by Revenue in OTC Anti-Infective Products in 2020
Figure 35. China OTC Anti-Infective Products Revenue Share by Type (2016-2021)
Figure 36. China OTC Anti-Infective Products Revenue Growth Rate by Type in 2016 & 2020
Figure 37. China OTC Anti-Infective Products Revenue Share by Application (2016-2021)
Figure 38. China OTC Anti-Infective Products Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America OTC Anti-Infective Products Sales Growth Rate 2016-2021 (K Units)
Figure 40. North America OTC Anti-Infective Products Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America OTC Anti-Infective Products Sales Market Share by Country in 2020
Figure 42. North America OTC Anti-Infective Products Revenue Market Share by Country in 2020
Figure 43. U.S. OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units)
Figure 44. U.S. OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units)
Figure 46. Canada OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Europe OTC Anti-Infective Products Sales Growth Rate 2016-2021 (K Units)
Figure 48. Europe OTC Anti-Infective Products Revenue Growth Rate 2016-2021 (US$ Million)
Figure 49. Europe OTC Anti-Infective Products Sales Market Share by Country in 2020
Figure 50. Europe OTC Anti-Infective Products Revenue Market Share by Country in 2020
Figure 51. Germany OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units)
Figure 52. Germany OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. France OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units)
Figure 54. France OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. U.K. OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units)
Figure 56. U.K. OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Italy OTC Anti-Infective Products Sales Growth Rate (2016-2021) (K Units)
Figure 58. Italy OTC Anti-Infective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Russia OTC Anti-Infective Prod

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs